首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Preliminary Results of the Outpatient Endovascular and Interventional Society National Registry
【24h】

Preliminary Results of the Outpatient Endovascular and Interventional Society National Registry

机译:门诊血管外和介入社会国家登记处的初步结果

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose: To present a new outcomes-based registry to collect data on outpatient endovascular interventions, a relatively new site of service without adequate historical data to assess best clinical practices. Quality data collection with subsequent outcomes analysis, benchmarking, and direct feedback is necessary to achieve optimal care. Materials and Methods: The Outpatient Endovascular and Interventional Society (OEIS) established the OEIS National Registry in 2017 to collect data on safety, efficacy, and quality of care for outpatient endovascular interventions. Since then, it has grown to include a peripheral artery disease (PAD) module with plans to expand to include cardiac, venous, dialysis access, and other procedures in future modules. As a Qualified Clinical Data Registry approved by the Centers for Medicare and Medicaid Services, this application also supports new quality measure development under the Quality Payment Program. All physicians operating in an office-based laboratory or ambulatory surgery center can use the Registry to analyze de-identified data and benchmark performance against national averages. Major adverse events were defined as death, stroke, myocardial infarction, acute onset of limb ischemia, index bypass graft or treated segment thrombosis, and/or need for urgent/emergent vascular surgery. Results: Since Registry inception in 2017, 251 participating physicians from 64 centers located in 18 states have participated. The current database includes 18,134 peripheral endovascular interventions performed in 12,403 PAD patients (mean age 72.3 +/- 10.2 years; 60.1% men) between January 2017 and January 2020. Cases were performed primarily in an office-based laboratory (85.1%) or ambulatory surgery center setting (10.4%). Most frequently observed procedure indications from 16,086 preprocedure form submissions included claudication (59%), minor tissue loss (16%), rest pain (9%), acute limb ischemia (5%), and maintenance of patency (3%). Planned diagnostic procedures made up 12.2% of cases entered, with the remainder indicated as interventional procedures (87.6%). The hospital transfer rate was 0.62%, with 88 urgent/emergent transfers and 24 elective transfers. The overall complication rate for the Registry was 1.87% (n=338), and the rate of major adverse events was 0.51% (n=92). Thirty-day mortality was 0.03% (n=6). Conclusion: This report describes the current structure, methodology, and preliminary results of OEIS National Registry, an outcomes-based registry designed to collect quality performance data with subsequent outcome analysis, benchmarking, and direct feedback to aid clinicians in providing optimal care.
机译:目的:提出一个新的基于结果的注册中心,以收集门诊血管内干预的数据,这是一个相对较新的服务场所,没有足够的历史数据来评估最佳临床实践。高质量的数据收集以及随后的结果分析、基准测试和直接反馈是实现最佳护理的必要条件。材料和方法:2017年,门诊血管内和介入学会(OEIS)建立了OEIS国家注册中心,以收集关于门诊血管内介入治疗的安全性、有效性和护理质量的数据。从那时起,它已经发展到包括外周动脉疾病(PAD)模块,并计划在未来的模块中扩展到包括心脏、静脉、透析通路和其他程序。作为医疗保险和医疗补助服务中心批准的合格临床数据注册中心,该应用程序还支持质量支付计划下的新质量度量开发。所有在基于办公室的实验室或门诊手术中心工作的医生都可以使用该注册中心来分析未识别的数据,并根据全国平均水平对绩效进行基准测试。主要不良事件定义为死亡、中风、心肌梗死、急性肢体缺血发作、指数旁路移植或治疗的节段血栓形成和/或需要紧急/紧急血管手术。结果:自2017年注册成立以来,来自18个州64个中心的251名参与医生参与了该项目。目前的数据库包括2017年1月至2020年1月期间对12403名PAD患者(平均年龄72.3+/-10.2岁;60.1%为男性)进行的18134次外周血管内干预。病例主要在办公室实验室(85.1%)或门诊手术中心(10.4%)进行。从16086份术前提交的表格中,最常观察到的手术适应症包括跛行(59%)、轻微组织丢失(16%)、静息痛(9%)、急性肢体缺血(5%)和保持通畅(3%)。计划诊断程序占入选病例的12.2%,其余为介入程序(87.6%)。医院转院率为0.62%,其中急诊转院88例,择期转院24例。登记的总并发症发生率为1.87%(n=338),主要不良事件发生率为0.51%(n=92)。30天死亡率为0.03%(n=6)。结论:本报告描述了OEIS国家注册中心(OEIS National Registry)的当前结构、方法和初步结果。OEIS国家注册中心是一个基于结果的注册中心,旨在收集质量绩效数据,并进行后续结果分析、基准测试和直接反馈,以帮助临床医生提供最佳护理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号